Unique vectors for gene therapy constructed in the test tube from
purified components of a pseudo-virus.
Overview
GENE VECTOR TECHNOLOGY LTD. (GVT) has developed gene delivery
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
system involving a new vector for gene therapy. The technology is
based on the characteristics of viruses as natural carriers of
genetic material to organism cells. By making particular
alterations to the virus it may be made to perform specific
desired functions in carrying genetic material to cells, e.g., to
restore damaged cells. Virus capsules are used as DNA packaging.
Today various technologies utilize viruses as carriers to tissue
cells in the body. The proposed technology utilizes the viral
vector SV40 and its preparation in a test tube from controlled
composites, yielding a pseudo-virus for use as a vector for gene
therapy. The procedure that is carried out in the test tube will
be more efficient and better controlled than if it was carried
out in a cell culture.
GVT's unique vector combines the efficiency of a viral vector
with the safety of a non-viral vector.
